Date: Saturday, June 11, 2016
Session Time: 5:30pm-7:30pm
Presentation Time: 5:30pm-7:30pm
Location: Halls C&D
The maturation of Continuous glucose monitoring (CGM) technology enables accurate characterization of daily glucose control. We investigated glucose control using CGM in the first 6 weeks after pancreas transplantation (PT) in patients with type 1 diabetes(T1D).
Between 2011 and 2015, 12 insulin independent T1D patients underwent CGM on post-operative days (POD) 20±7 for 3.8 ± 1.5 days. The data were analyzed using appropriate CGM measures of glucose control. Measurements include standard measures such as mean ± SD and state of the art CGM related statistics such as % time spent in various glucose ranges and indices of hypo and hyperglycemia and average daily risk range (ADRR).
Table 1 shows demographic data. Glucose control is described in Table 2. Mean blood glucose (BG) was observed to be 128.1 with SD of 13.1. Number of BG readings was 864.42 ± 397.4 during this whole period with average number of readings per day 190 ± 96.9. 91.8% of readings were in range between 70 to 180mg/dl with 0.5% below 70mg/dl and 7.8% above 180mg/dl. Average daily risk range (ADRR) 15.5 ± 15.3 with Low blood glucose index (LBGI) of 0.4 ± 0.5 and High blood glucose index (HBGI) of 2.6 ± 2.4.
|Age at Transplant||48.5 ± 9|
|POD CGM started||20 ± 7|
|Duration of CGM days||3.8 ± 1.5|
|CGM reading||All Patients||SPK||PAK||P value|
|Number of readings||864±397.4||764.3±192.2||964.5±535.3||0.42|
|Mean readings per day||190± 96.9||182.5±20.8||197.5±31.6||0.36|
CGM provides a reliable method of monitoring glucose control after pancreas transplantation. We are currently acquiring more data regarding glucose control after PT. CGM outcomes represent an important objective outcome after PT that requires inclusion in prospective studies of PT.
CITATION INFORMATION: Bonner K, Dadlani V, Thapa P, Stegall M, Kudva Y. Continuous Glucose Monitoring in the First 6 Weeks After Transplantation in Pancreas Transplant Recipients. Am J Transplant. 2016;16 (suppl 3).
To cite this abstract in AMA style:Bonner K, Dadlani V, Thapa P, Stegall M, Kudva Y. Continuous Glucose Monitoring in the First 6 Weeks After Transplantation in Pancreas Transplant Recipients. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/continuous-glucose-monitoring-in-the-first-6-weeks-after-transplantation-in-pancreas-transplant-recipients/. Accessed March 31, 2020.
« Back to 2016 American Transplant Congress